Aptus Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.77M | Sell |
|
|||||
|
2025
Q2 | $3.03M | Sell |
|
|||||
|
2025
Q1 | $19M | Buy |
|
|||||
|
2024
Q4 | $16.2M | Buy |
|
|||||
|
2024
Q3 | $1.12M | Buy |
|
|||||
|
2024
Q2 | $719K | Buy |
|
|||||
|
2024
Q1 | $909K | Buy |
|
|||||
|
2023
Q4 | $742K | Sell |
|
|||||
|
2023
Q3 | $3.38M | Buy |
|
|||||
|
2023
Q2 | $3.67M | Sell |
|
|||||
|
2023
Q1 | $4.2M | Buy |
|
|||||
|
2022
Q4 | $3.15M | Buy |
|
|||||
|
2022
Q3 | $2.88M | Buy |
|
|||||
|
2022
Q2 | $3.02M | Buy |
|
|||||
|
2022
Q1 | $606K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $2.81M | Buy |
|
|||||
|
2020
Q1 | $2.44M | Buy |
|
|||||
|
2019
Q4 | $2.45M | Buy |
|
|||||
|
2019
Q3 | $1.49M | Buy |
|